Lataa...
Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose‐volume analysis
Bevacizumab is a monoclonal antibody against vascular endothelial growth factor that exerts antitumor effect by preventing tumor angiogenesis. Gastrointestinal fistula is a common side effect of bevacizumab in combination with radiotherapy. This case of rectovaginal fistula indicates that the side e...
Tallennettuna:
| Julkaisussa: | Clin Case Rep |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8077241/ https://ncbi.nlm.nih.gov/pubmed/33936646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3955 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|